Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Gleevec in NF1 with Plexiform Neurofibromas
NCT01140360Phase 2Completed
- Start
- Feb 2012
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in neurofibromatosis type 1 (NF1). Primary endpoint: Disease Response at 1 year. Started Feb 2012; status: completed.
02
Drugs
03
Conditions
neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on NCT01140360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01140360.